Association of liver enzymes with incident type 2 diabetes: A nested case control study in an Iranian population

BMC Endocrine Disorders

Volumn 8, Issue , 2008, Pages

  Tohidi, Maryam ^a   Harati, Hadi ^a   Hadaegh, Farzad ^a   Mehrabi, Yadolladh ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; INSULIN; LIVER ENZYME;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FACTORIAL ANALYSIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; IRAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

EID: 46349083764     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-8-5     Document Type: Article

References (27)

1. Schindhelm RK Diamant M Dekker JM Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease Diabetes Metab Res Rev 2006, 22:437-43. 10.1002/dmrr.666 16832839
2. Marchesini G Brizi M Bianchi G Tomassetti S Nonalcoholic fatty liver disease: A feature of the metabolic syndrome Diabetes 2001, 50:1844-50. 10.2337/diabetes.50.8.1844 11473047
3. Marchesini G Bugianesi E Forlani G Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 2003, 37:917-23. 10.1053/jhep.2003.50161 12668987
4. Dixon JB Bhathal PS O'Brien PE Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 2001, 121:91-100. 10.1053/ gast.2001.25540 11438497
5. Mulhall BP Ong JP Younossi ZM Non-alcoholic fatty liver disease: An overview J Gastroenterol Hepatol 2002, 17:1136-43. 10.1046/ j.1440-1746.2002.02881.x 12453271
6. Angulo P Lindor KD Non-alcoholic fatty liver disease J Gastroenterol Hepatol 2002, 17(Suppl):S186-90. 10.1046/j.1440-1746.17.s1.10.x 12000605
7. André P Balkau B Born C Hepatic markers and development of type 2 diabetes in middle aged men and women: A three-year follow-up study The D.E.S.I.R. Study. Diabetes Metab 2005, 31:542-50.
8. Nakanishi N Suzuki K Tatara K Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men Diabetes Care 2004, 27:1427-32. 10.2337/diacare.27.6.1427 15161799
9. Vozarova B Stefan N Lindsay RS High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes Diabetes 2002, 51:1889-95. 10.2337/ diabetes.51.6.1889 12031978
10. Sattar N Scherbakova O Ford I Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study Diabetes 2004, 53:2855-60. 10.2337/ diabetes.53.11.2855 15504965
11. Hanley AJ Williams K Festa A Elevations in markers of liver injury and risk of type 2 diabetes: The insulin resistance atherosclerosis study Diabetes 2004, 53:2623-32. 10.2337/diabetes.53.10.2623 15448093
12. Perry IJ Wannamethee SG Shaper AG Prospective study of serum gamma-glutamyltransferase and risk of NIDDM Diabetes Care 1998, 21:732-7. 10.2337/diacare.21.5.732 9589232
13. Azizi F Rahmani M Emami H Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1) Soz Praventivmed 2002, 47:408-26. 12643001
14. Greenland S Schwartzbaum JA Finkle WD Problems due to small samples and sparse data in conditional logistic regression analysis Am J Epidemiol 2000, 151:531-9. 10707923
15. Peduzzi P Concato J Kemper E A simulation study of the number of events per variable in logistic regression analysis J Clin Epidemiol 1996, 49:1373-9. 10.1016/S0895-4356(96)00236-3 8970487
16. Marjorie A Pett Eleanor J Sullivan Lackey Making Sense of Factor Analysis Sage Publications. California, USA; 2003.
17. DeLong ER DeLong DM Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach Biometrics 1988, 44:837-844. 10.2307/2531595 3203132
18. Lee DH Silventoinen K Jacobs DR Jr gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: Observational cohort study among 20,158 middle-aged men and women J Clin Endocrinol Metab 2004, 89:5410-4. 10.1210/jc.2004-0505 15531490
19. Lee DH Ha MH Kim JH Gamma-glutamyltransferase and diabetes-a 4 year follow-up study Diabetologia 2003, 46:359-64. 10.1007/s00125-003-1226-1 12687334
20. Schindhelm RK Dekker JM Nijpels G No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study Diabetes Care 2005, 28:2812. 10.2337/diacare.28.11.2812 16249570
21. Nannipieri M Gonzales C Baldi S Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico City diabetes study Diabetes Care 2005, 28:1757-62. 10.2337/diacare.28.7.1757 15983331
22. Tiikkainen M Bergholm R Vehkavaara S Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content Diabetes 2003, 52:701-7. 10.2337/ diabetes.52.3.701 12606511
23. Day C Saksena S Non-alcoholic steatohepatitis: Definitions and pathogenesis J Gastroenterol Hepatol 2002, 17:S377-S384. 10.1046/ j.1440-1746.17.s3.31.x 12472967
24. Ceriello A Motz E Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 2004, 24:816-23. 10.1161/01.ATV.0000122852.22604.78 14976002
25. Lloyd-Jones DM Liu K Tian L Greenland P Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease Ann Intern Med 2006, 145:35-42. 16818927
26. Wannamethee SG Shaper AG Lennon L Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men Diabetes Care 2005, 28:2913-8. 10.2337/diacare.28.12.2913 16306554
27. Gholamreza R Shahryar S Abbasali K Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population Indian J Med Sci 2007, 61:263-8. 17478956